Targeting endothelial dysfunction in vascular complications associated with diabetes

International Journal of Vascular Medicine

Volumn 2012, Issue , 2012, Pages

  Sharma, Arpeeta ^a,b   Bernatchez, Pascal N ^b   De Haan, Judy B ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; COPPER ZINC SUPEROXIDE DISMUTASE; EBSELEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FASUDIL; GLUTATHIONE PEROXIDASE 1; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; RHO KINASE; TETRAHYDROBIOPTERIN;

CARDIOVASCULAR MORTALITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; HUMAN; NONHUMAN; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VASCULAR ENDOTHELIUM;

EID: 84856106488     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2012/750126     Document Type: Review

References (118)

1. Dunstan D. W., Zimmet P. Z., Welborn T. A., De Courten M. P., Cameron A. J., Sicree R. A., Dwyer T., Colagiuri S., Jolley D., Knuiman M., Atkins R., Shaw J. E., The rising prevalence of diabetes and impaired glucose tolerance: the Australian diabetes, obesity and lifestyle study. Diabetes Care 2002 25 5 829 834 2-s2.0-0036582654 10.2337/diacare.25.5.829 (Pubitemid 41094278)
2. Narayan K. M. V., Boyle J. P., Thompson T. J., Sorensen S. W., Williamson D. F., Lifetime risk for diabetes mellitus in the United States. JAMA 2003 290 14 1884 1890 2-s2.0-0141991939 10.1001/jama.290.14.1884 (Pubitemid 37430605)
3. Thompson D., Wolf A. M., The medical-care cost burden of obesity. Obesity Reviews 2001 2 3 189 197 2-s2.0-0035427946 (Pubitemid 33755912)
4. Lockhart C. J., Hamilton P. K., McVeigh K. A., McVeigh G. E., A cardiologist view of vascular disease in diabetes. Diabetes, Obesity and Metabolism 2008 10 4 279 292 2-s2.0-40749136251 10.1111/j.1463-1326.2007.00727.x (Pubitemid 351386025)
5. Grundy S. M., Benjamin I. J., Burke G. L., Chait A., Eckel R. H., Howard B. V., Mitch W., Smith S. C., Sowers J. R., Diabetes and cardiovascular disease: a statement for healthcare professionals from the american heart association. Circulation 1999 100 10 1134 1146 2-s2.0-0033533596 (Pubitemid 29416243)
6. Standl E., Balletshofer B., Dahl B., Weichenhain B., Stiegler H., Hörmann A., Holle R., Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia 1996 39 12 1540 1545 2-s2.0-0029857628 10.1007/s001250050612 (Pubitemid 26397365)
7. Schram M. T., Kostense P. J., Van Dijk R. A. J. M., Dekker J. M., Nijpels G., Bouter L. M., Heine R. J., Stehouwer C. D. A., Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. Journal of Hypertension 2002 20 9 1743 1751 2-s2.0-0036734199 10.1097/00004872-200209000-00017
8. Cosentino F., Lüscher T. F., Endothelial dysfunction in diabetes mellitus. Journal of Cardiovascular Pharmacology 1998 32 supplement 3 S54 S61 (Pubitemid 29019754)
9. Haller H., Endothelial function. General considerations. Drugs 1997 53 supplement 1 1 10 2-s2.0-0031046435 (Pubitemid 27101586)
10. Furchgott R. F., Zawadzki J. V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980 288 5789 373 376 2-s2.0-0019195506 (Pubitemid 11169009)
11. Lloyd-Jones D. M., Bloch K. D., The vascular biology of nitric oxide and its role in atherogenesis. Annual Review of Medicine 1996 47 365 375 2-s2.0-0029983521 10.1146/annurev.med.47.1.365 (Pubitemid 26138897)
12. Ming X. F., Viswambharan H., Barandier C., Ruffieux J., Kaibuchi K., Rusconi S., Yang Z., Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Molecular and Cellular Biology 2002 22 24 8467 8477 2-s2.0-0036892061 10.1128/MCB.22.24.8467-8477.2002 (Pubitemid 35397163)
13. Alderton W. K., Cooper C. E., Knowles R. G., Nitric oxide synthases: structure, function and inhibition. Biochemical Journal 2001 357 3 593 615 2-s2.0-0035425503 10.1042/0264-6021:3570593 (Pubitemid 32735142)
14. Sharma A., Yu C., Bernatchez P. N., New insights into caveolae, caveolins and endothelial function. The Canadian Journal of Cardiology 2010 26 supplement A 5A 8A 2-s2.0-77952777662
15. Xu Y., Buikema H., van Gilst W. H., Henning R. H., Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease. European Journal of Pharmacology 2008 585 2-3 256 260 2-s2.0-43049124748 10.1016/j.ejphar.2008.02.086
16. McVeigh G. E., Brennan G. M., Johnston G. D., McDermott B. J., McGrath L. T., Henry W. R., Andrews J. W., Hayes J. R., Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992 35 8 771 776 2-s2.0-0026684462
17. Huszka M., Kaplar M., Rejto L., Tornai I., Palatka K., Laszlo P., Udvardy M., The association of reduced endothelium derived relaxing factor-no production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus. Thrombosis Research 1997 86 2 173 180 2-s2.0-0030911304 10.1016/S0049-3848(97)00060-1 (Pubitemid 27235129)
18. Tiefenbacher C. P., Kreuzer J., Nitric oxide-mediated endothelial dysfunctionis there need to treat? Current Vascular Pharmacology 2003 1 2 123 133 2-s2.0-16544374138
19. Cosentino F., Hishikawa K., Katusic Z. S., Lüscher T. F., High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997 96 1 25 28 2-s2.0-0030837996 (Pubitemid 27298398)
20. Ding H., Aljofan M., Triggle C. R., Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells. Journal of Cellular Physiology 2007 212 3 682 689 2-s2.0-34547946423 10.1002/jcp.21063 (Pubitemid 47267538)
21. El-Remessy A. B., Tawfik H. E., Matragoon S., Pillai B., Caldwell R. B., Caldwell R. W., Peroxynitrite mediates diabetes-induced endothelial dysfunction: possible role of Rho kinase activation. Experimental Diabetes Research 2010 2010 9 247861 10.1155/2010/247861
22. Ding H., Hashem M., Triggle C., Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS. European Journal of Pharmacology 2007 561 13 121 128 2-s2.0-33947258419 10.1016/j.ejphar.2006.12.034 (Pubitemid 46435847)
23. Giacco F., Brownlee M., Oxidative stress and diabetic complications. Circulation Research 2010 107 9 1058 1070 2-s2.0-78349297565 10.1161/CIRCRESAHA.110.223545
24. Chen C. A., Wang T. Y., Varadharaj S., Reyes L. A., Hemann C., Talukder M. A. H., Chen Y. R., Druhan L. J., Zweier J. L., S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 2010 468 7327 1115 1120 2-s2.0-78650810596 10.1038/nature09599
25. Chen C. A., Superoxide induces eNOS protein Thiyl radical formation: a novel mechanism regulating eNOS function and coupling. The Journal of Biological Chemistry 2011 286 33 29098 29107
26. Cave A. C., Brewer A. C., Narayanapanicker A., Ray R., Grieve D. J., Walker S., Shah A. M., NADPH oxidases in cardiovascular health and disease. Antioxidants and Redox Signaling 2006 8 5-6 691 728 2-s2.0-33745883797 10.1089/ars.2006.8.691 (Pubitemid 44043102)
27. Wendt M. C., Daiber A., Kleschyov A. L., Mülsch A., Sydow K., Schulz E., Chen K., Keaney J. F., Lassègue B., Walter U., Griendling K. K., Münzel T., Differential effects of diabetes on the expression of the gp91 phox homologues nox1 and nox4. Free Radical Biology and Medicine 2005 39 3 381 391 2-s2.0-21344434376 10.1016/j.freeradbiomed.2005.03.020 (Pubitemid 40910195)
28. Gao X., Zhang H., Schmidt A. M., Zhang C., AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic mice. American Journal of Physiology 2008 295 2 H491 H498 2-s2.0-52449094718 10.1152/ajpheart.00464.2008
29. Olukman M., Orhan C. E., Çelenk F. G., Ülker S., Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions. Journal of Diabetes and Its Complications 2010 24 6 415 423 2-s2.0-77956547219 10.1016/j.jdiacomp.2010.02.001
30. Unger B., Patil B., Apocynin improves endothelial function and prevents the development of hypertension in fructose fed rat. Indian Journal of Pharmacology 2009 41 5 208 212 2-s2.0-74249106864 10.4103/0253-7613.58508
31. Leo C. H., Joshi A., Woodman O. L., Short-term type 1 diabetes alters the mechanism of endothelium-dependent relaxation in the rat carotid artery. American Journal of Physiology 2010 299 2 H502 H511 2-s2.0-77955435182 10.1152/ajpheart.01197.2009
32. Hempel A., Maasch C., Heintze U., Lindschau C., Dietz R., Luft F. C., Haller H., High glucose concentrations increase endothelial cell permeability via activation of protein kinase C α Circulation Research 1997 81 3 363 371 2-s2.0-0030743466 (Pubitemid 27362523)
33. Inoguchi T., Sonta T., Tsubouchi H., Etoh T., Kakimoto M., Sonoda N., Sato N., Sekiguchi N., Kobayashi K., Sumimoto H., Utsumi H., Nawata H., Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. Journal of the American Society of Nephrology 2003 14 3 S227 S232 2-s2.0-18144447696 (Pubitemid 36903930)
34. Inoguchi T., Li P., Umeda F., Yu H. Y., Kakimoto M., Imamura M., Aoki T., Etoh T., Hashimoto T., Naruse M., Sano H., Utsumi H., Nawata H., High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000 49 11 1939 1945 2-s2.0-0033765672
35. Yang G., Lucas R., rlucas@mcg.edu Caldwell R., Yao L., Romero M., Caldwell R., Novel mechanisms of endothelial dysfunction in diabetes. Journal of Cardiovascular Disease Research 2010 1 2 59 63 10.4103/0975-3583.64432
36. Vasquez-Vivar J., Martasek P., Whitsett J., Joseph J., Kalyanaraman B., The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochemical Journal 2002 362 3 733 739 2-s2.0-0037086565 10.1042/0264-6021:3620733 (Pubitemid 34242326)
37. Heitzer T., Krohn K., Albers S., Meinertz T., Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia 2000 43 11 1435 1438 2-s2.0-0033752910 10.1007/s001250051551
38. Alp N. J., Channon K. M., Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 3 413 420 2-s2.0-1542283780 10.1161/01.ATV.0000110785. 96039.f6 (Pubitemid 38326132)
39. 4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovascular Research 2005 65 4 823 831 2-s2.0-13844281183 10.1016/j.cardiores.2004.10.040 (Pubitemid 40249727)
40. Alp N. J., Mussa S., Khoo J., Cai S., Guzik T., Jefferson A., Goh N., Rockett K. A., Channon K. M., Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. The Journal of Clinical Investigation 2003 112 5 725 735 2-s2.0-0141612000 10.1172/JCI200317786 (Pubitemid 38057713)
41. Wohlfart P., Xu H., Endlich A., Habermeier A., Closs E. I., Hübschle T., Mang C., Strobel H., Suzuki T., Kleinert H., Förstermann U., Ruetten H., Li H., Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling. Journal of Pharmacology and Experimental Therapeutics 2008 325 2 370 379 2-s2.0-42449083767 10.1124/jpet.107.128009 (Pubitemid 351574784)
42. Frantz S., Adamek A., Fraccarollo D., Tillmanns J., Widder J. D., Dienesch C., Schäfer A., Podolskaya A., Held M., Ruetten H., Ertl G., Bauersachs J., The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury. Basic Research in Cardiology 2009 104 6 773 779 2-s2.0-70349652240 10.1007/s00395-009-0041-3
43. Yang Q., qyang@surgery.cuhk.edu.hk Xue H.-M., Wong W.-T., Tian X.-Y., Huang Y., Tsui S. K., Ng P. K., Wohlfart P., Li H., Xia N., Tobias S., Underwood M. J., He G.-W., heguowei@nankai.edu.cn AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats. British Journal of Pharmacology 2011 163 5 1078 1085 10.1111/j.1476-5381.2011.01308.x
44. Wolfrum S., Dendorfer A., Rikitake Y., Stalker T. J., Gong Y., Scalia R., Dominiak P., Liao J. K., Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 10 1842 1847 2-s2.0-5344268785 10.1161/01.ATV.0000142813.33538.82 (Pubitemid 39350301)
45. Mallat Z., Gojova A., Sauzeau V., Brun V., Silvestre J. S., Esposito B., Merval R., Groux H., Loirand G., Tedgui A., Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circulation Research 2003 93 9 884 888 2-s2.0-0242266962 10.1161/01.RES.0000099062.55042.9A (Pubitemid 37363063)
46. Kishi T., Hirooka Y., Masumoto A., Ito K., Kimura Y., Inokuchi K., Tagawa T., Shimokawa H., Takeshita A., Sunagawa K., Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure. Circulation 2005 111 21 2741 2747 2-s2.0-20344383268 10.1161/CIRCULATIONAHA.104.510248 (Pubitemid 40791544)
47. Fukumoto Y., Matoba T., Ito A., Tanaka H., Kishi T., Hayashidani S., Abe K., Takeshita A., Shimokawa H., Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension. Heart 2005 91 3 391 392 2-s2.0-14244260105 10.1136/hrt.2003.029470 (Pubitemid 40299237)
48. John S., Schneider M. P., Delles C., Jacobi J., Schmieder R. E., Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. American Heart Journal 2005 149 3, article 473 2-s2.0-17844408136 10.1016/j.ahj.2004.06.027 (Pubitemid 40585410)
49. Osende J. I., Ruiz-Ortega M., Blanco-Colio L. M., Egido J., Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study. Nephrology Dialysis Transplantation 2004 19 3 528 531 2-s2.0-1342306224 10.1093/ndt/gfg538 (Pubitemid 38263106)
50. Mancini G. B. J., Henry G. C., Macaya C., O'Neill B. J., Pucillo A. L., Carere R. G., Wargovich T. J., Mudra H., Lüscher T. F., Klibaner M. I., Haber H. E., Uprichard A. C. G., Pepine C. J., Pitt B., Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing ENdothelial Dysfunction) study. Circulation 1996 94 3 258 265 2-s2.0-9444280103 (Pubitemid 26266107)
51. O'Driscoll G., Green D., Maiorana A., Stanton K., Colreavy F., Taylor R., Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. Journal of the American College of Cardiology 1999 33 6 1506 1511 2-s2.0-0033133528 10.1016/S0735-1097(99)00065-0
52. Pieper G. M., Dondlinger L. A., Plasma and vascular tissue arginine are decreased in diabetes: acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production. Journal of Pharmacology and Experimental Therapeutics 1997 283 2 684 691 2-s2.0-0030779576 (Pubitemid 27514627)
53. Karuppiah K., Suppression of eNOS-derived superoxide by caveolin-1: a biopterin-dependent mechanism. American Journal of Physiology 2011 301 3 H903 H911
54. Searles C. D., Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression. American Journal of Physiology 2006 291 5 C803 C816 2-s2.0-33751104228 10.1152/ajpcell.00457.2005 (Pubitemid 44771801)
55. Xie Z., Su W., Guo Z., Pang H., Post S. R., Gong M. C., Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells. Cardiovascular Research 2006 69 2 491 501 2-s2.0-30744461632 10.1016/j.cardiores.2005.11.002 (Pubitemid 43098805)
56. Ali T. K., Al-Gayyar M. M. H., Matragoon S., Pillai B. A., Abdelsaid M. A., Nussbaum J. J., El-Remessy A. B., aelremessy@mcg.edu Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury. Diabetologia 2011 54 3 657 668 10.1007/s00125-010-1935-1
57. Arita R., Hata Y., Nakao S., Kita T., Miura M., Kawahara S., Zandi S., Almulki L., Tayyari F., Shimokawa H., Hafezi-Moghadam A., Ishibashi T., Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Diabetes 2009 58 1 215 226 2-s2.0-62949150229 10.2337/db08-0762
58. Eto M., Barandiér C., Rathgeb L., Kozai T., Joch H., Yang Z., Lüscher T. F., Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circulation Research 2001 89 7 583 590 2-s2.0-0035964808 (Pubitemid 32924212)
59. Satoh K. M. D., Fukumoto Y., Shimokawa H., Rho-kinase: important new therapeutic target in cardiovascular diseases. American Journal of Physiology 2011 301 2 H287 H296
60. Ying H., Biroc S. L., Li W. W., Alicke B., Xuan J. A., Pagila R., Ohashi Y., Okada T., Kamata Y., Dinter H., The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models. Molecular Cancer Therapeutics 2006 5 9 2158 2164 2-s2.0-33749538874 10.1158/1535-7163.MCT-05-0440 (Pubitemid 44530451)
61. García-Cardeña G., Martasek P., Masters B. S. S., Skidd P. M., Couet J., Li S., Lisanti M. P., Sessa W. C., Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. The Journal of Biological Chemistry 1997 272 41 25437 25440 2-s2.0-0039397709 10.1074/jbc.272.41.25437 (Pubitemid 27438846)
62. Ju H., Zou R., Venema V. J., Venema R. C., Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. The Journal of Biological Chemistry 1997 272 30 18522 18525 2-s2.0-0030853953 10.1074/jbc.272.30.18522 (Pubitemid 27318186)
63. Bernatcher P. N., Bauer P. M., Yu J., Prendergast J. S., He P., Sessa W. C., Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. Proceedings of the National Academy of Sciences of the United States of America 2005 102 3 761 766 2-s2.0-14144250454 10.1073/pnas.0407224102 (Pubitemid 40282739)
64. Liu J., García-Cardeña G., Sessa W. C., Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 1996 35 41 13277 13281 2-s2.0-0029847608 10.1021/bi961720e (Pubitemid 26349419)
65. Zhao Y. Y., Liu Y., Stan R. V., Fan L., Gu Y., Dalton N., Chu P. H., Peterson K., Ross J., Chien K. R., Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proceedings of the National Academy of Sciences of the United States of America 2002 99 17 11375 11380 2-s2.0-0037143769 10.1073/pnas.172360799 (Pubitemid 34920933)
66. Bauer P. M., Yu J., Chen Y., Hickey R., Bernatchez P. N., Looft-Wilson R., Huang Y., Giordano F., Stan R. V., Sessa W. C., Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 2005 102 1 204 209 2-s2.0-19944428563 10.1073/pnas.0406092102 (Pubitemid 40094453)
67. Murata T., Lin M. I., Huang Y., Yu J., Bauer P. M., Giordano F. J., Sessa W. C., Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. Journal of Experimental Medicine 2007 204 10 2373 2382 2-s2.0-34948904709 10.1084/jem.20062340 (Pubitemid 47529323)
68. Elciolu K. H., Kabasakal L., Çetinel Ş., Conturk G., Sezen S. F., Ayanolu-Dülger G., Changes in caveolin-1 expression and vasoreactivity in the aorta and corpus cavernosum of fructose and streptozotocin-induced diabetic rats. European Journal of Pharmacology 2010 642 13 113 120 2-s2.0-77954689257 10.1016/j.ejphar.2010.05.049
69. Zeydanli E. N., Kandilci H. B., Turan B., belma.turan@medicine.ankara. edu.tr Doxycycline ameliorates vascular endothelial and contractile dysfunction in the thoracic aorta of diabetic rats. Cardiovascular Toxicology 2011 11 2 134 147 10.1007/s12012-011-9107-1
70. McGuire J. F., Rouen S., Siegfreid E., Wright D. E., Dobrowsky R. T., Caveolin-1 and altered neuregulin signaling contribute to the pathophysiological progression of diabetic peripheral neuropathy. Diabetes 2009 58 11 2677 2686 2-s2.0-70350523813 10.2337/db09-0594
71. Bernatchez P. N., A non-inhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice. The Journal of Clinical Investigation 2011 121 93 3747 3755
72. Bedard K., Krause K. H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007 87 1 245 313 2-s2.0-33846794822 10.1152/physrev.00044.2005 (Pubitemid 46209993)
73. Kakehi T., Yabe-Nishimura C., NOX enzymes and diabetic complications. Seminars in Immunopathology 2008 30 3 301 314 2-s2.0-47149085420 10.1007/s00281-008-0122-7
74. Lee M. Y., Martin A. S., Mehta P. K., Dikalova A. E., Garrido A. M., Datla S. R., Lyons E., Krause K. H., Banfi B., Lambeth J. D., Lassègue B., Griendling K. K., Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 4 480 487 2-s2.0-63449105018 10.1161/ATVBAHA.108.181925
75. de Haan J. B., Cooper M. E., Targeted antioxidant therapies in hyperglycemia-mediated endothelial dysfunction. Frontiers in Bioscience 2011 3 709 729
76. Gupte S., Labinskyy N., Gupte R., Csiszar A., Ungvari Z., Edwards J. G., Role of NAD(P)H oxidase in superoxide generation and endothelial dysfunction in Goto-Kakizaki (GK) rats as a model of nonobese NIDDM. PLoS One 2010 5 7 2-s2.0-77955640337 10.1371/journal.pone.0011800 e11800
77. Stielow C., Catar R. A., Muller G., Wingler K., Scheurer P., Schmidt H. H. H. W., Morawietz H., Henning.Morawietz@tu-dresden.de Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells. Biochemical and Biophysical Research Communications 2006 344 1 200 205 10.1016/j.bbrc.2006.03.114
78. Rey F. E., Cifuentes M. E., Kiarash A., Quinn M. T., Pagano P. J., Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O2- and systolic blood pressure in mice. Circulation Research 2001 89 5 408 414 2-s2.0-0035980160 (Pubitemid 34132656)
79. Zhou M. S., Schulman I. H., Pagano P. J., Jaimes E. A., Raij L., Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension 2006 47 1 81 86 2-s2.0-31744449213 10.1161/01.HYP.0000197182.65554.c7 (Pubitemid 43177819)
80. Heumüller S., Wind S., Barbosa-Sicard E., Schmidt H. H. H. W., Busse R., Schröder K., Brandes R. P., Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008 51 2 211 217 2-s2.0-38549138327 10.1161/HYPERTENSIONAHA.107.100214 (Pubitemid 351159930)
81. de Haan J. B., Crack P. J., Flentjar N., Iannello R. C., Hertzog P. J., Kola I., An imbalance in antioxidant defense aftfects cellular function: the pathophysiological consequences of a reduction in antioxidant defense in the glutathione peroxidase-1 (Gpx1) knockout mouse. Redox Report 2003 8 2 69 79 2-s2.0-0037274133 10.1179/135100003125001378 (Pubitemid 36511762)
82. Chávez M. D., Lakshmanan N., Kavdia M., Impact of superoxide dismutase on nitric oxide and peroxynitrite levels in the microcirculationa computational model. Proceedings of the 29th Annual International Conference of IEEE-EMBS, Engineering in Medicine and Biology Society (EMBC '07) August 2007 1022 1026 2-s2.0-57649183723 10.1109/IEMBS.2007.4352468
83. Cooke C. L. M., Davidge S. T., Endothelial-dependent vasodilation is reduced in mesenteric arteries from superoxide dismutase knockout mice. Cardiovascular Research 2003 60 3 635 642 2-s2.0-0344196789 10.1016/j.cardiores. 2003.08.011 (Pubitemid 37501121)
84. Goto H., Nishikawa T., Sonoda K., Kondo T., Kukidome D., Fujisawa K., Yamashiro T., Motoshima H., Matsumura T., Tsuruzoe K., Araki E., Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice. Biochemical and Biophysical Research Communications 2008 366 3 814 820 2-s2.0-37549066364 10.1016/j.bbrc.2007.12.041
85. Maxwell S. R. J., Thomason H., Sandler D., Leguen C., Baxter M. A., Thorpe G. H. G., Jones A. F., Barnett A. H., Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. European Journal of Clinical Investigation 1997 27 6 484 490 2-s2.0-0030797118 (Pubitemid 27288358)
86. Uchimura K., Nagasaka A., Hayashi R., Makino M., Nagata M., Kakizawa H., Kobayashi T., Fujiwara K., Kato T., Iwase K., Shinohara R., Kato K., Itoh M., Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus. Journal of Diabetes and its Complications 1999 13 5-6 264 270 2-s2.0-0033549921 10.1016/S1056-8727(99)00053-7 (Pubitemid 30182606)
87. Opara E. C., Abdel-Rahman E., Soliman S., Kamel W. A., Souka S., Lowe J. E., Abdel-Aleem S., Depletion of total antioxidant capacity in type 2 diabetes. Metabolism 1999 48 11 1414 1417 2-s2.0-0032698380 (Pubitemid 29536441)
88. Suys B., De Beeck L. O., Rooman R., Kransfeld S., Heuten H., Goovaerts I., Vrints C., De Wolf D., Matthys D., Manuel-Y-Keenoy B., Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type 1 diabetes mellitus: protection by superoxide dismutase? Pediatric Research 2007 62 4 456 461 2-s2.0-34748904175 10.1203/PDR.0b013e318142581a (Pubitemid 47476205)
89. Zanetti M., Sato J., Katusic Z. S., O'Brien T., Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta. American Journal of Physiology 2001 280 6 H2516 H2523 2-s2.0-0034987628
90. Ceriello A., Dello Russo P., Amstad P., Cerutti P., High glucose induces antioxidant enzymes in human endothelial cells in culture; Evidence linking hyperglycemia and oxidative stress. Diabetes 1996 45 4 471 477 2-s2.0-0029875833
91. Lee I. M., Cook N. R., Gaziano J. M., Gordon D., Ridker P. M., Manson J. E., Hennekens C. H., Buring J. E., Vitamin E in the primary prevention of cardiovascular disease and cancer. The women's health study: a randomized controlled trial. JAMA 2005 294 1 56 65 2-s2.0-21444438990 10.1001/jama.294.1.56 (Pubitemid 41002839)
92. Sheikh-Ali M., Chehade J. M., Mooradian A. D., arshag.mooradian@jax.ufl. edu The antioxidant paradox in diabetes mellitus. American Journal of Therapeutics 2011 18 3 266 278 10.1097/MJT.0b013e3181b7badf
93. DeRubertis F. R., Craven P. A., Melhem M. F., Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol. Metabolism 2007 56 9 1256 1264 2-s2.0-34547693219 10.1016/j.metabol.2007.04.024 (Pubitemid 47223266)
94. Rosales M. A., Silva K. C., Lopes de Faria J. B., Lopes de Faria J. M., Exogenous SOD mimetic tempol ameliorates the early retinal changes reestablishing the redox status in diabetic hypertensive rats. Investigative Ophthalmology & Visual Science 2010 51 8 4327 4336 2-s2.0-77955858949
95. Schnackenberg C. G., Wilcox C. S., The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney International 2001 59 5 1859 1864 2-s2.0-0035050847 10.1046/j.1523-1755.2001. 0590051859.x (Pubitemid 32336801)
96. Weber D. S., Griendling K. K., The Yin/Yang of superoxide dismutase mimetics: potential cardiovascular therapies? British Journal of Pharmacology 2003 139 6 1059 1060 2-s2.0-0041668080 10.1038/sj.bjp.0705353 (Pubitemid 36920667)
97. Witting P. K., Rayner B. S., Wu B. J., Ellis N. A., Stocker R., Hydrogen peroxide promotes endothelial dysfunction by stimulating multiple sources of superoxide anion radical production and decreasing nitric oxide bioavailability. Cellular Physiology and Biochemistry 2007 20 5 255 268 2-s2.0-34548361213 10.1159/000107512 (Pubitemid 47340589)
98. Brigelius-Flohé R., Banning A., Schnurr K., Selenium-dependent enzymes in endothelial cell function. Antioxidants and Redox Signaling 2003 5 2 205 215 2-s2.0-0037392209 (Pubitemid 36457596)
99. Esterbauer H., Wag G., Puhl H., Lipid peroxidation and its role in atherosclerosis. British Medical Bulletin 1993 49 3 566 576 2-s2.0-0027199039 (Pubitemid 23243830)
100. Sies H., Sharov V. S., Klotz L. O., Briviba K., Glutathione peroxidase protects against peroxynitrite-mediated oxidations: a new function for selenoproteins as peroxynitrite reductase. The Journal of Biological Chemistry 1997 272 44 27812 27817 2-s2.0-0030834975 10.1074/jbc.272.44.27812 (Pubitemid 27473581)
101. Forgione M. A., Cap A., Liao R., Moldovan N. I., Eberhardt R. T., Lim C. C., Jones J., Goldschmidt-Clermont P. J., Loscalzo J., Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation 2002 106 9 1154 1158 2-s2.0-0037183563 10.1161/01.CIR.0000026820.87824.6A (Pubitemid 34970859)
102. Blankenberg S., Rupprecht H. J., Bickel C., Torzewski M., Hafner G., Tiret L., Smieja M., Cambien F., Meyer J., Lackner K. J., Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. The New England Journal of Medicine 2003 349 17 1605 1613 2-s2.0-0142057430 10.1056/NEJMoa030535 (Pubitemid 37288568)
103. de Haan J. B., Bladier C., Griffiths P., Kelner M., O'Shea R. D., Cheung N. S., Bronson R. T., Silvestro M. J., Wild S., Zheng S. S., Beart P. M., Hertzog P. J., Kola I., Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress- inducing agents paraquat and hydrogen peroxide. The Journal of Biological Chemistry 1998 273 35 22528 22536 2-s2.0-14444271790 10.1074/jbc.273.35.22528 (Pubitemid 28399820)
104. Esposito L. A., Kokoszka J. E., Waymire K. G., Cottrell B., MacGregor G. R., Wallace D. C., Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene. Free Radical Biology and Medicine 2000 28 5 754 766 2-s2.0-0034062554 10.1016/S0891-5849(00)00161-1 (Pubitemid 30171289)
105. Yoshida T., Maulik N., Engelman R. M., Ho Y. S., Magnenat J. L., Rousou J. A., Flack J. E., Deaton D., Das D. K., Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation 1997 96 9, supplement II216 II220 2-s2.0-0342871961 (Pubitemid 27500034)
106. Lewis P., Stefanovic N., Pete J., Calkin A. C., Giunti S., Thallas-Bonke V., Jandeleit-Dahm K. A., Allen T. J., Kola I., Cooper M. E., De Haan J. B., Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 2007 115 16 2178 2187 2-s2.0-34247540770 10.1161/CIRCULATIONAHA.106.664250 (Pubitemid 46659070)
107. Forgione M. A., Weiss N., Heydrick S., Cap A., Klings E. S., Bierl C., Eberhardt R. T., Farber H. W., Loscalzo J., Cellular glutathione peroxidase deficiency and endothelial dysfunction. American Journal of Physiology 2002 282 4 H1255 H1261 2-s2.0-0036084994 (Pubitemid 34654876)
108. Fumeron F., Reis A. F., Velho G., Genetics of macrovascular complications in diabetes. Current Diabetes Reports 2006 6 2 162 168 2-s2.0-33645767496 10.1007/s11892-006-0028-5
109. Galasso G., Schiekofer S., Sato K., Shibata R., Handy D. E., Ouchi N., Leopold J. A., Loscalzo J., Walsh K., Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circulation Research 2006 98 2 254 261 2-s2.0-33644866801 10.1161/01.RES.0000200740.57764.52
110. Ardanaz N., Yang X. P., Cifuentes M. E., Haurani M. J., Jackson K. W., Liao T. D., Carretero O. A., Pagano P. J., Lack of glutathione peroxidase 1 accelerates cardiac-specific hypertrophy and dysfunction in angiotensin II hypertension. Hypertension 2010 55 1 116 123 2-s2.0-73849152789 10.1161/HYPERTENSIONAHA.109.135715
111. Chrissobolis S., Didion S. P., Kinzenbaw D. A., Schrader L. I., Dayal S., Lentz S. R., Faraci F. M., Glutathione peroxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction. Hypertension 2008 51 4 872 877 2-s2.0-42049105594 10.1161/HYPERTENSIONAHA.107.103572 (Pubitemid 351654698)
112. Chew P., Yuen D. Y. C., Stefanovic N., Pete J., Coughlan M. T., Jandeleit-Dahm K. A., Thomas M. C., Rosenfeldt F., Cooper M. E., De Haan J. B., Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse. Diabetes 2010 59 12 3198 3207 2-s2.0-78650042004 10.2337/db10-0195
113. Chew P., Yuen D. Y.C., Koh P., Stefanovic N., Febbraio M. A., Kola I., Cooper M. E., De Haan J. B., judy.dehaan@bakeridi.edu.au Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 6 823 830 10.1161/ATVBAHA.109.186619
114. Sui H., Wang W., Wang P. H., Liu L. S., Effect of glutathione peroxidase mimic ebselen (PZ51) on endothelium and vascular structure of stroke-prone spontaneously hypertensive rats. Blood Pressure 2005 14 6 366 372 2-s2.0-31344462069 10.1080/08037050500210781 (Pubitemid 43135735)
115. Brodsky S. V., Gealekman O., Chen J., Zhang F., Togashi N., Crabtree M., Gross S. S., Nasjletti A., Goligorsky M. S., Prevention and reversal of
116. Ali N., Yoshizumi M., Tsuchiya K., Kyaw M., Fujita Y., Izawa Y., Abe S., Kanematsu Y., Kagami S., Tamaki T., Ebselen inhibits p38 mitogen-activated protein kinase-mediated endothelial cell death by hydrogen peroxide. European Journal of Pharmacology 2004 485 13 127 135 2-s2.0-20244373738 10.1016/j.ejphar.2003.11.079 (Pubitemid 38134406)
117. Bhabak K. P., Mugesh G., Amide-based glutathione peroxidase mimics: effect of secondary and amide substituents on antioxidant activity. ChemistryAn Asian Journal 2009 4 6 974 983 2-s2.0-67650666166 10.1002/asia.200800483
118. Hort M. A., Straliotto M. R., Netto P. M., Da Rocha J. B. T., De Bem A. F., andrezadebem@ccb.ufsc.br Ribeiro-Do-Valle R. M., Diphenyl diselenide effectively reduces atherosclerotic lesions in LDLr -/- Mice by attenuation of oxidative stress and inflammation. Journal of Cardiovascular Pharmacology 2011 58 1 91 101 10.1097/FJC.0b013e31821d1149